Q & A

China Daily talked to Yin Xudong, chairman of Novartis Greater China, with a focus on the company's ongoing development of research and development capability in China.

Q: Please tell us a little more about your new facility in Shanghai.

A: I believe we are unique in China in the industry. It is because first, we want to be different from other pharmaceutical companies, and second, we have already made a head start on the plan. Based on our strategic plan for China, we have built up all these capabilities, primarily in Shanghai.